Cimpress (CMPR)
(Delayed Data from NSDQ)
$88.32 USD
-1.81 (-2.01%)
Updated May 17, 2024 04:00 PM ET
After-Market: $88.28 -0.04 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$88.32 USD
-1.81 (-2.01%)
Updated May 17, 2024 04:00 PM ET
After-Market: $88.28 -0.04 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Zacks News
Cimpress (CMPR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cimpress (CMPR) delivered earnings and revenue surprises of -30.65% and 2.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cimpress (CMPR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cimpress (CMPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Avoid Betting on Cimpress (CMPR) Now
by Zacks Equity Research
Cimpress (CMPR) has been suffering from low bookings across its segments due to the soft-demand environment amid the coronavirus outbreak. Also, the company's high debt level remains concerning.
Cimpress (CMPR) to Gain From Acquisitions Despite Headwinds
by Zacks Equity Research
Cimpress (CMPR) is likely to benefit from strong product portfolio, acquired assets and shareholder-friendly policies. However, high debt and the coronavirus outbreak-related issues are concerning.
Cimpress' Financial Results Update Shows Y/Y Drop in Bookings
by Zacks Equity Research
Cimpress' (CMPR) consolidated bookings for April and May decline on a y/y basis.
Cimpress (CMPR) Up 18.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cimpress (CMPR) Declines 38% YTD: What's Hurting the Stock?
by Zacks Equity Research
Cimpress (CMPR) is experiencing low bookings across its segments on account of the coronavirus outbreak-led market downturn. Also, its high debt level and low liquidity remain concerning.
Cimpress (CMPR) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Cimpress' (CMPR) third-quarter fiscal 2020 revenues decrease y/y on account of lackluster performance across most of its segments.
Cimpress (CMPR) Beats Q3 Earnings Estimates
by Zacks Equity Research
Cimpress (CMPR) delivered earnings and revenue surprises of 15.09% and -0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Cimpress (CMPR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cimpress (CMPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cimpress (CMPR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cimpress (CMPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Cimpress Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Cimpress has been struggling lately, but the selling pressure may be coming to an end soon.
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
by Zacks Equity Research
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
What Bargain Hunting? Tap 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
G-III Apparel (GIII) Stock Gains on Earnings Beat in Q4
by Zacks Equity Research
G-III Apparel (GIII) posts robust fourth-quarter fiscal 2020 earnings on impressive brand strength and strategic efforts. It did not provide outlook for fiscal 2021 due to the coronavirus crisis.
3 Stocks Witnessing Momentum Anomaly Amid Coronavirus Crisis
by Zacks Equity Research
These fast movers are currently witnessing a short-term pullback in price, as COVID-19 pandemic rattles market. So, this could essentially be a great entry point for higher returns.
Is Cimpress (CMPR) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Is Cimpress (CMPR) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Investors Should Bet on Cimpress (CMPR) Stock Now
by Zacks Equity Research
Favorable trends in Cimpress' (CMPR) PrintBrothers business, expanded product line and the BuildASign buyout augur well for its growth.
Why Cimpress (CMPR) Could Be Positioned for a Surge
by Zacks Equity Research
Cimpress (CMPR) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Rent-A-Center (RCII) Stock Up on Q4 Earnings & Revenue Beat
by Zacks Equity Research
Rent-A-Center (RCII) puts up a stellar fourth-quarter 2019 performance on impressive gains from lease portfolio and an integrated retail partner model.
Zacks.com featured highlights include: Anixter International, Cincinnati Financial, Cimpress and Federated Hermes
by Zacks Equity Research
Zacks.com featured highlights include: Anixter International, Cincinnati Financial, Cimpress and Federated Hermes
4 Top-Ranked Momentum Stocks Based on Driehaus Strategy
by Nitish Marwah
Investors who have a tendency to take high level of risks can choose momentum stocks as an investment option.
Cimpress Offers Senior Notes, to Use Funds for Repaying Debt
by Zacks Equity Research
Cimpress (CMPR) intends to utilize the funds from offering of its senior notes for repaying a part of outstanding debt under its revolving credit facility.